Recent news on Olux

Stiefel Laboratories Moves to Solidify, Enhance Its Leadership ...  -  Apr 23, 2007
PR Newswire (press release),Luxiq(R) (betamethasone valerate) Foam, 0.12%; MimyX(TM) Cream; Olux(R) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam,

Stiefel Laboratories Moves to Solidify, Enhance Its Leadership ...  -  Apr 23, 2007
PharmaLive.com (press release),Luxiq(R) (betamethasone valerate) Foam, 0.12%; MimyX(TM) Cream; Olux(R) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam,

Stiefel Laboratories, Inc. Donates First Dermatology Ward in ...  -  Feb 2, 2007
Drug Newswire (press release),Some of the best-known brands include Sarna(R), Duac(R) Topical Gel, MimyX(TM) Cream, Olux(R), Brevoxyl(R) Creamy Wash, Oilatum(R), Soriatane(R),

Stiefel Laboratories, Inc. Completes Acquisition of Connetics ...  -  Dec 29, 2006
PharmaLive.com (press release),Some of the best-known brands include Sarna(R), Duac(R) Topical Gel, MimyX(TM) Cream, Olux(R), Brevoxyl(R)Creamy Wash, Oilatum(R), Soriatane(R), Evoclin(R),

Stiefel Laboratories, Inc. Completes Acquisition of Connetics ...  -  Dec 28, 2006
Yahoo! News (press release)Some of the best-known brands include Sarna®, Duac® Topical Gel, MimyX(TM) Cream, Olux®, Brevoxyl®Creamy Wash, Oilatum®, Soriatane®, Evoclin®, Verdeso(TM)

Connetics Announces Results of Special Stockholders Meeting  -  Dec 20, 2006
Genetic Engineering News (press release),The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin)

Connetics Announces Results of Special Stockholders Meeting  -  Dec 20, 2006
Business Wire (press release),The Company's marketed products are OLUX ® (clobetasol propionate) Foam, 0.05%; Luxíq ® (betamethasone valerate) Foam, 0.12%; Soriatane ® (acitretin)

Connetics Announces Results of Special Stockholders Meeting  -  Dec 20, 2006
Genetic Engineering News (press release),The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin)

Connetics Announces Results of Special Stockholders Meeting  -  Dec 20, 2006
Business Wire (press release),The Company's marketed products are OLUX ® (clobetasol propionate) Foam, 0.05%; Luxíq ® (betamethasone valerate) Foam, 0.12%; Soriatane ® (acitretin)

Stiefel Laboratories Rated 'B+'; Secured Debt Also Rated  -  Dec 6, 2006
PharmaLive.com (press release),The company will have a diverse product portfolio, with its top three products--Duac, Soriatane, and Olux--collectively accounting for only 34% of total

Connetics Launches Verdeso Foam for the Treatment of Mild-to ...  Nov 8, 2006
...for Connetics, said, “Verdeso provides a great opportunity for our sales force to leverage the reputation of our leading Luxíq ® and OLUX ® brands, both ... -Business Wire (press release), Connetics Corporation to Merge into Stiefel Laboratories  Oct 24, 2006
The Company's commercial products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin ... -Drug Newswire (press release), Stiefel to purchase Connetics  Oct 24, 2006
Cream with Sunscreens. Connetics sells Olux Foam, Luxiq Foam, Soriatane capsules, Evoclin Foam and Verdeso Foam. The company's development ... -San Antonio Business Journal, Stiefel Plans $640M Acquisition Of Dermatology Firm Connetics  Oct 23, 2006
The company turned its attention to such products as Olux (clobetasol propionate) and Luxiq (betamethasone valerate) foams, marketed for scalp dermatoses. ... -BioWorld Online, Connetics Corporation to Merge into Stiefel Laboratories  Oct 23, 2006
The Company's commercial products are OLUX® (clobetasol propionate) Foam, 0.05%; Luxiq® (betamethasone valerate) Foam, 0.12%; Soriatane® (acitretin) capsules ... -Yahoo! News (press release) Connetics Corporation and Stiefel Laboratories, Inc. Sign ...  Oct 23, 2006
The Company's commercial products are OLUX ® (clobetasol propionate) Foam, 0.05%; Luxiq ® (betamethasone valerate) Foam, 0.12%; Soriatane ® (acitretin ... -Business Wire (press release), FDA Approves Connetics' Eczema Drug  Sep 20, 2006
Verdeso is the company's first low-potency steroid product. Connetics already markets Luxiq, a mid-potency drug, and Olux, a super-high potency drug. ... -Houston Chronicle

FDA Approves Connetics' Verdeso Foam for the Treatment of Mild-to ...  Sep 20, 2006
...of Connetics, said, "We have established leading brands in the topical mid- and super-high potency steroid categories with Luxiq(R) and OLUX(R), respectively. ... -PharmaLive.com

Perrigo: FDA Tentatively OKs Scalp Foam  Sep 1, 2006
...said Friday its Israeli unit received tentative approval from the Food and Drug Administration for a generic version of Olux Foam, a drug to treat scalp ... -Houston Chronicle

Perrigo's generic foam gets tentative OK  Sep 1, 2006
1 (UPI) -- Perrigo said Friday the Food and Drug Administration has granted tentative approval to its generic version of Connetic's Olux foam. ... -United Press International

Perrigo gets tentative FDA nod for generic scalp psoriasis foam  Sep 1, 2006
...(PRGO.O: Quote, Profile, Research) on Friday said its Israeli unit has received tentative US regulatory approval for its generic version of Olux, a foam to ... -Reuters

FDA tentatively approves Perrigo psoriasis treatment  Sep 3, 2006
Sales of the ethical version of the treatment, Olux, totaled $78 million in the twelve months ending July. Perrigo Co. (Agis Industries ... -Globes

Lawsuit holds back launch of product Perrigo's set to make  Sep 5, 2006
The Connetics Corp., based in New Jersey, holds the patent for Olux Foam, a prescription medication used in the treatment of skin inflammations, primarily of ... -MLive.com

New Rogaine(R) Foam Features Connetics' Proprietary VersaFoam(R) ...  Sep 5, 2006
Connetics' VersaFoam-based products are OLUX(R) for scalp dermatoses and non-scalp psoriasis, Luxiq(R) Foam for scalp dermatoses and Evoclin(R) Foam for the ... -Business Wire

Perrigo Receives Tentative Approval For Clobetasol Propionate Foam  Sep 1, 2006
0.05%. The reference listed drug (Olux® Foam, 0.05%, Connetics Corporation) is subject to a period of patent protection. Perrigo ... -Yahoo! News

Connetics Reports Positive Results From Second Phase III Clinical ...  Aug 28, 2006
Connetics has branded its proprietary foam drug delivery vehicle VersaFoam(R). The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05 ... -Genetic Engineering News

Perrigo (PRGO) Receives Tentative FDA Approval for its Clobetasol ...  Sep 1, 2006
0.05%. The reference listed drug (Olux(R) Foam, 0.05%, Connetics Corporation) is subject to a period of patent protection. Perrigo ... -StreetInsider.com (subscription)

Stiefel Laboratories Rated 'B+'; Secured Debt Also Rated  -  Dec 6, 2006
PharmaLive.com (press release),The company will have a diverse product portfolio, with its top three products--Duac, Soriatane, and Olux--collectively accounting for only 34% of total

Connetics Announces Special Meeting of Stockholders to Approve ...  -  Nov 17, 2006
Business Wire (press release),The Company's marketed products are OLUX ® (clobetasol propionate) Foam, 0.05%; Luxíq ® (betamethasone valerate) Foam, 0.12%; Soriatane ® (acitretin)

Connetics Reports Positive Results From Second Phase III Clinical ...  29 Aug 2006
Connetics has branded its proprietary foam drug delivery vehicle VersaFoam(R). The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05 ... -PipelineReview.com

Connetics Reports Second Quarter Financial Results  Aug 14, 2006
Second quarter 2006 revenues include Soriatane(R) sales of $16.3 million, OLUX(R) sales of $12.2 million, Evoclin(R) sales of $9.3 million and Luxiq(R) sales ... -Business Wire

Scout leader's fall tragedy  Aug 18, 2006
The body of Mr Underhill, the lead guitarist with a local band, was found at the bottom of a valley at the ski resort of Sauze d'Olux, near the Olympic city of ... -expressandstar.com

CORRECTED - UPDATE 1-Connetics warns on profit; shares plunge  Jul 10, 2006
The Palo Alto, California-based, which makes drugs for the dermatology market such as Olux and Luxiq for scalp conditions such as scalp psoriasis, said ... -Reuters

Connetics warns on profit; shares plunge  Jul 10, 2006
The Palo Alto, California-based company, whose products include Olux and Luxiq for conditions such as scalp psoriasis, said it expected second quarter and full ... -Reuters

Connetics Announces Extension and Changes in Terms of Convertible ...  Jul 19, 2006
Connetics has branded its proprietary foam drug delivery vehicle VersaFoam(R). The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05 ... -Business Wire

Skier, 24, died of cold  Jul 13, 2006
Mr Underhill, aged 24, of Evers Street, was unable to scramble back up the valley at the ski resort of Sauze d'Olux, near the Olympic city of Turin in Italy. ... -expressandstar.com



Connetics Reports Preliminary Results for First Quarter 2006 ...  May 3, 2006
Total revenues for the first quarter of 2006 were $47.7 million, including Soriatane(R) sales of $19.0 million, OLUX(R) sales of $14.1 million, Evoclin(R ... - PharmaLive.com

Connetics Names Sunil Patel Vice President, Corporate Development ...  May 9, 2006
Connetics has branded its proprietary foam drug delivery vehicle VersaFoam(R). The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05 ... - PharmaLive.com





Connetics Provides Information on Securities and Exchange ...  Apr 7, 2006
Connetics has branded its proprietary foam drug delivery vehicle VersaFoam(R). The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05 ... - PharmaLive.com



Welder killed in snow plunge  Feb 24, 2006
Welder Shane Underhill, aged 24, of Evers Street, was found at the bottom of a valley at the ski resort of Sauze d'Olux, near the Olympic city of Turin. ... - expressandstar.com,

Connetics Names Freddie Park Vice President, Intellectual Property ...  Feb 6, 2006
Connetics has branded its proprietary foam drug delivery vehicle VersaFoam(R). The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05 ... - Genetic Engineering News

Connetics Reports Fourth Quarter Revenues of $41.3 Million and EPS ...  Jan 31, 2006
Fourth quarter 2005 product revenues included OLUX(R) sales of $14.7 million, Soriatane(R) sales of $13.6 million, Evoclin(TM) sales of $6.9 million and Luxiq(R ... - Genetic Engineering News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional